Gennex Laboratories Schedules Board Meeting on 14th Nov'26 to Consider Q2 Results
Gennex Laboratories Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Gennex Laboratories Schedules Board Meeting on 14th Nov'26 to Consider Q2 Results Gennex Laboratories Limited has scheduled a Board of Directors meeting on 14th Nov'26 to consider and adopt the unaudited standalone and consolidated financial results, along with the Statutory Auditor's Limited Review Reports, for the quarter and half-year ended 30th Sep'26. The company's trading window for dealing in securities, which closed on 1st Oct'26, will reopen 48 hours after the declaration of the financial results for all designated and connected persons.
Original exchange filing (PDF)
More announcements from Gennex Laboratories Ltd
- Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., November .... 路 15 Nov 2026
- Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in their meeting held on November 14, 2026, reconstituted Audit .... 路 15 Nov 2026
- 1. Unaudited (Standalone and Consolidated) Financial Results for the Quarter and Half year ended September 30, 2026 along with the Statement of Assets and Liabilities as at September 30, .... 路 14 Nov 2026
- The Board of Directors of the Company at its meeting held today, i.e. Saturday, November 14, 2026 has considered and approved the following items: 1. Unaudited (Standalone and Consolidated) .... 路 14 Nov 2026
- In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time, please find enclosed herewith voting results of the 41st eAGM of the Company held on September .... 路 01 Oct 2026
- Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we would like to inform you that the Company has received approval of its members by Special .... 路 30 Sept 2026
- Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to provide hereunder the proceedings of 41st eAGM of the Company held on Wednesday, September 30, 2026 through .... 路 30 Sept 2026
- We are pleased to inform that our subsidiary company, M/s Deccan Remedies Limited has received approval from the Drugs Control Administration, Government of Andhra Pradesh granting License .... 路 08 Sept 2026
